Phoenix Financial Ltd. lowered its stake in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 2.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,350 shares of the medical research company’s stock after selling 130 shares during the quarter. Phoenix Financial Ltd.’s holdings in Agilent Technologies were worth $513,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Stone House Investment Management LLC acquired a new stake in Agilent Technologies during the 1st quarter worth approximately $30,000. Ransom Advisory Ltd acquired a new stake in Agilent Technologies during the 1st quarter worth approximately $32,000. Central Pacific Bank Trust Division acquired a new stake in Agilent Technologies during the 2nd quarter worth approximately $33,000. Zions Bancorporation National Association UT acquired a new stake in Agilent Technologies during the 1st quarter worth approximately $38,000. Finally, Costello Asset Management INC acquired a new stake in Agilent Technologies during the 1st quarter worth approximately $47,000.
Wall Street Analyst Weigh In
A has been the subject of a number of research analyst reports. Rothschild & Co Redburn initiated coverage on shares of Agilent Technologies in a research report on Wednesday, October 8th. They set a “buy” rating and a $165.00 target price for the company. Weiss Ratings reissued a “hold (c)” rating on shares of Agilent Technologies in a research report on Wednesday, October 8th. Robert W. Baird increased their target price on shares of Agilent Technologies from $141.00 to $142.00 and gave the stock an “outperform” rating in a research report on Thursday, August 28th. Barclays increased their price objective on shares of Agilent Technologies from $125.00 to $150.00 and gave the company an “equal weight” rating in a research report on Thursday, October 2nd. Finally, Rothschild Redb raised shares of Agilent Technologies to a “strong-buy” rating in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Agilent Technologies currently has an average rating of “Moderate Buy” and a consensus price target of $149.62.
Agilent Technologies Stock Performance
Agilent Technologies stock opened at $146.01 on Thursday. The stock has a market cap of $41.39 billion, a P/E ratio of 34.27, a price-to-earnings-growth ratio of 4.76 and a beta of 1.26. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The stock has a 50 day moving average of $129.24 and a 200-day moving average of $118.56. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $153.84.
Agilent Technologies (NYSE:A – Get Free Report) last released its earnings results on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, meeting the consensus estimate of $1.37. The company had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business’s revenue was up 10.1% on a year-over-year basis. During the same period in the prior year, the business posted $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.
Agilent Technologies Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th were paid a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Tuesday, September 30th. Agilent Technologies’s dividend payout ratio is 23.24%.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Featured Articles
- Five stocks we like better than Agilent Technologies
- Are Penny Stocks a Good Fit for Your Portfolio?
- Archer’s Recent String of Victories Signals a New Phase of Growth
- The 3 Best Fintech Stocks to Buy Now
- 3 Key Stocks Boosting Buybacks Amid Improving Fundamentals
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- The Best AI for Picking Stocks, Ranked by Performance
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.